← Evidence map

ArticleProceedings of the National Academy of Sciences of the United States of America2009

A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.

Veronika Jenei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

87 papers cite itlatest 60 shown

2009
…
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 19901340